Quantitative Reverse-Transcription Polymerase Chain Reaction Analysis of Alzheimer's-Associated Genes in Mouse Scrapie

REFERENCES

• Agostinho, P., Lopes, J. P., Velez, Z., and Oliveira, C. R., 2008. Overactivation of calcineurin induced by amyloid-beta and prion proteins, Neurochem. Int. (2008), doi:10.1016/j.neuint. 2008.01.005.
   PubMed Web of Science ®Google Scholar
• Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and Landfield, P. W., 2004. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses, Proc. Natl. Acad. Sci. USA 101 (2004), pp. 2173–2178.
   PubMed Web of Science ®Google Scholar
• Booth, S., Bowman, C., Baumgartner, R., Sorensen, G., Robertson, C., Coulthart, M., Phillipson, C., and Somorjai, R. L., 2004. Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection, J. Gen. Virol. 85 (2004), pp. 3459–3471.
   PubMed Web of Science ®Google Scholar
• Cortijo–Arellano, M., Ponce, J., Durany, N., and Cladera, J., 2008. Amyloidgenic properties of the prion protein fragment PrP(185-208): Comparison with Alzheimer's peptide Aß(1 -28), influence of heparin and cell toxicity, Biochem. Biophys. Res. Commun. 368 (2008), pp. 238–242.
   PubMed Web of Science ®Google Scholar
• Counts, S. E., Perez, S. E., Ginsberg, S. D., De Lacalle, S., and Mufson, E. J., 2003. Galanin in Alzheimer disease, Mol. Interv. 3 (2003), pp. 137–156.
   PubMedGoogle Scholar
• Crozet, C., Vézilier, J., Delfieu, V., Nishimura, T., Onodera, T., and Casanova, D., 2006. The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic, Mol. Cell. Neurosci. 32 (2006), pp. 315–323.
   PubMed Web of Science ®Google Scholar
• Ding, X., MacTavish, D., Kar, S., and Jhamandas, J. H., 2006. Galanin attenuates beta amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons, Neurobiol. Dis. 21 (2006), pp. 413–420.
   PubMed Web of Science ®Google Scholar
• Harrison, R. S., Sharpe, P. C., Singh, Y., and Fairlie, D. P., 2007. Amyloid peptides and proteins in review, Rev. Physiol. Biochem. Pharmacol. 159 (2007), pp. 1–77.
   PubMed Web of Science ®Google Scholar
• Hun Lim, K., Collver, H. H., Le, Y. T. H., Nagchowdhuri, P., and Kenny, J. M., 2007. Characteristics of distinct amyloidogenic conformations of the Aß(1-40) and (1-42) peptides, Biochem. Biophys. Res. Commun. 353 (2007), pp. 443–449.
   PubMed Web of Science ®Google Scholar
• McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., DeLucia, M., Lin, W. L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., and Golde, T., 2005. Aß42 is essential for parenchymal and vascular amyloid deposition in mice, Neuron 47 (2005), pp. 191–199.
   PubMed Web of Science ®Google Scholar
• Mirnics, K., Korade, Z., Arion, D., Lazarov, O., Unger, T., Macioce, M., Sabatini, M., Terrano, D., Douglass, K. C., Schor, N. F., and Sisodia, S. S., 2005. Presenilin-1-dependent transcriptome changes, J Neurosci. 25 (2005), pp. 1571–1578.
   PubMed Web of Science ®Google Scholar
• Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., and LaFerla, F. M., 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aß and synaptic dysfunction, Neuron 39 (2003), pp. 409–421.
   PubMed Web of Science ®Google Scholar
• Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., and Domenici, L., 2008. Receptor for advanced glycation end product -dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta -mediated cortical synaptic dysfunction, J. Neurosci. 28 (2008), pp. 3521–3530.
   PubMed Web of Science ®Google Scholar
• Parkin, E. T., Watt, N. T., Hussain, I., Echman, E. A., Eckman, C. B., Manson, J. C., Baybutt, H. N., Turner, A. J., and Hooper, N. M., 2007. Cellular prion protein regulates ß-secretase cleavage of the Alzheimer's amyloid precursor protein, Proc.Natl. Acad. Sci. USA 104 (2007), pp. 11062–11067.
   PubMed Web of Science ®Google Scholar
• Prusiner, S. B., 2001. Neurodegenerative diseases and prions, N. Engl. J. Med. 344 (2001), pp. 1516–1526.
   PubMed Web of Science ®Google Scholar
• Prusiner, S. B., 1998. Prions, Proc. Natl. Acad. Sci. USA 95 (1998), pp. 13363–13383.
   PubMed Web of Science ®Google Scholar
• Reddy, P.H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R., Mori, M., and Quinn, J., 2004. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease, Hum. Mol. Genet. 13 (2004), pp. 1225–1240.
   PubMed Web of Science ®Google Scholar
• Reimer, C., Neidhold, S., Burwinkel, M., Schwarz, A., Schultz, J., Kratzschmar, J., Monning, U., and Baier, M., 2004. Gene expression profiling of scrapie-infected brain tissue, Biochem. Biophys. Res. Commun. 323 (2004), pp. 556–564.
   PubMed Web of Science ®Google Scholar
• Sasaki, N., Takeuchi, M., Chowei, H., Kikuchi, S., Hayashi, Y., Nakano, N., Ikeda, H., Yamagishi, S., Kitamoto, T., Saito, T., and Makita, Z., 2002. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt–Jakob disease with prion plaques, Neurosci. Lett. 326 (2002), pp. 117–120.
   PubMed Web of Science ®Google Scholar
• Sisó, S., Puig, B., Varea, R., Vidal, E., Acín, C., Prinz, M., Montrasio, F., Badiola, J., Aguzzi, A., Pumarola, M., and Ferrer, I., 2002. Abnormal synaptic protein expression and cell death in murine scrapie, Acta Neuropathol. 103 (2002), pp. 615–626.
   PubMed Web of Science ®Google Scholar
• Sorensen, G., Medina, S., Parchaliuk, D., Phillipson, C., Robertson, C., and Booth, S. A., 2008. Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes, BMC Genom. 3 (9) (2008), p. 114.
   Google Scholar
• Stockley, J. H., Ravid, R., and O'Neill, C., 2006. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain, FEBS Left. 580 (2006), pp. 6550–6560.
   PubMed Web of Science ®Google Scholar
• Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., and Barnham, K. J., 2008. Stabilization of neurotoxic soluble ßsheet-rich conformations of the Alzheimer's disease amyloid-ß peptide, Biophys. J. 94 (2008), pp. 2752–2766, .
   PubMed Web of Science ®Google Scholar
• Vincent, B., Cisse, M. A., Sunyach, C., Guillot-Sestier, M. V., and Checler, F., 2008. Regulation of betaAPP and PrPc cleavage by alpha-secretase: Mechanistic and therapeutic perspectives, Curr. Alzheimer Res. 5 (2008), pp. 202–211.
   PubMed Web of Science ®Google Scholar
• Vincent, I., Jicha, G., Rosado, M., and Dickson, D. W., 1997. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain, J. Neurosci. 17 (1997), pp. 3588–3598.
   PubMed Web of Science ®Google Scholar
• Winklhofer, K., Tatzelt, J., and Haass, C., 2008. The two faces of protein misfolding:Gain- and loss-of-function in neurodegenerative diseases, EMBO J. 27 (2008), pp. 336–349.
   PubMed Web of Science ®Google Scholar
• Wisniewski, T., and Sigurdsson, M., 2007. Therapeutic approaches for prion Alzheimer's diseases, FEBS J. 274 (2007), pp. 3784–3798.
   PubMed Web of Science ®Google Scholar
• Xiang, W., Windl, O., Wunsch, G., Dugas, M., Kohlmann, A., Dierkes, N., Westner, I. M., and Kretzschmar, H. A., 2004. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology, J. Virol. 78 (2004), pp. 11051–11060.
   PubMed Web of Science ®Google Scholar